122 related articles for article (PubMed ID: 17928679)
1. Soymorphins, novel mu opioid peptides derived from soy beta-conglycinin beta-subunit, have anxiolytic activities.
Ohinata K; Agui S; Yoshikawa M
Biosci Biotechnol Biochem; 2007 Oct; 71(10):2618-21. PubMed ID: 17928679
[TBL] [Abstract][Full Text] [Related]
2. Antinociceptive potencies of beta-casomorphin analogs as compared to their affinities towards mu and delta opiate receptor sites in brain and periphery.
Brantl V; Pfeiffer A; Herz A; Henschen A; Lottspeich F
Peptides; 1982; 3(5):793-7. PubMed ID: 6294635
[TBL] [Abstract][Full Text] [Related]
3. Guinea-pig ileum (GPI) and mouse vas deferens (MVD) preparations in the discovery, discrimination and parallel bioassay of opioid peptides.
Erspamer GF; Severini C
Pharmacol Res; 1992 Sep; 26(2):109-21. PubMed ID: 1329062
[TBL] [Abstract][Full Text] [Related]
4. Cyclic beta-casomorphin analogues with mixed mu agonist/delta antagonist properties: synthesis, pharmacological characterization, and conformational aspects.
Schmidt R; Vogel D; Mrestani-Klaus C; Brandt W; Neubert K; Chung NN; Lemieux C; Schiller PW
J Med Chem; 1994 Apr; 37(8):1136-44. PubMed ID: 8164255
[TBL] [Abstract][Full Text] [Related]
5. Opioid activity of pro-enkephalin-derived peptides in mouse vas deferens and guinea pig ileum.
Sánchez-Blázquez P; Garzón J
Neurosci Lett; 1985 Nov; 61(3):267-71. PubMed ID: 3001596
[TBL] [Abstract][Full Text] [Related]
6. Structure-activity relationships of cyclic beta-casomorphin-5 analogues.
Schmidt R; Neubert K; Barth A; Liebmann C; Schnittler M; Chung NN; Schiller PW
Peptides; 1991; 12(6):1175-80. PubMed ID: 1667685
[TBL] [Abstract][Full Text] [Related]
7. Orally administered soymorphins, soy-derived opioid peptides, suppress feeding and intestinal transit via gut mu(1)-receptor coupled to 5-HT(1A), D(2), and GABA(B) systems.
Kaneko K; Iwasaki M; Yoshikawa M; Ohinata K
Am J Physiol Gastrointest Liver Physiol; 2010 Sep; 299(3):G799-805. PubMed ID: 20616303
[TBL] [Abstract][Full Text] [Related]
8. Orphanin FQ has an inhibitory effect on the guinea pig ileum and the mouse vas deferens.
Zhang G; Murray TF; Grandy DK
Brain Res; 1997 Oct; 772(1-2):102-6. PubMed ID: 9406961
[TBL] [Abstract][Full Text] [Related]
9. Soymorphin-5, a soy-derived μ-opioid peptide, decreases glucose and triglyceride levels through activating adiponectin and PPARα systems in diabetic KKAy mice.
Yamada Y; Muraki A; Oie M; Kanegawa N; Oda A; Sawashi Y; Kaneko K; Yoshikawa M; Goto T; Takahashi N; Kawada T; Ohinata K
Am J Physiol Endocrinol Metab; 2012 Feb; 302(4):E433-40. PubMed ID: 22127231
[TBL] [Abstract][Full Text] [Related]
10. Beta-endorphin. Biological activity of analogs containing dermorphin and dynorphin sequences: ileum and vas deferens assays.
Ho CL; Li CH
Int J Pept Protein Res; 1987 Jan; 29(1):134-9. PubMed ID: 2883148
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and biological activity of homoarginine-containing opioid peptides.
Izdebski J; Kunce D; Schiller PW; Chung NN; Gers T; Zelman M; Grabek M
J Pept Sci; 2007 Jan; 13(1):27-30. PubMed ID: 16967435
[TBL] [Abstract][Full Text] [Related]
12. Cyclic morphiceptin analogs: cyclization studies and opioid activities in vitro.
Vogel D; Schmidt R; Hartung K; Demuth HU; Chung NN; Schiller PW
Int J Pept Protein Res; 1996 Dec; 48(6):495-502. PubMed ID: 8985782
[TBL] [Abstract][Full Text] [Related]
13. Effect of aromatic amino acid substitutions in the 3-position of cyclic beta-casomorphin analogues on mu-opioid agonist/delta-opioid antagonist properties.
Schmidt R; Wilkes BC; Chung NN; Lemieux C; Schiller PW
Int J Pept Protein Res; 1996 Nov; 48(5):411-9. PubMed ID: 8956074
[TBL] [Abstract][Full Text] [Related]
14. Determination of the receptor selectivity of opioid agonists in the guinea-pig ileum and mouse vas deferens by use of beta-funaltrexamine.
Hayes AG; Sheehan MJ; Tyers MB
Br J Pharmacol; 1985 Dec; 86(4):899-904. PubMed ID: 3000501
[TBL] [Abstract][Full Text] [Related]
15. Characterization of the spinal antinociceptive activity of constrained peptidomimetic opioids.
Yaksh TL; Malmberg AB; Ro S; Schiller P; Goodman M
J Pharmacol Exp Ther; 1995 Oct; 275(1):63-72. PubMed ID: 7562596
[TBL] [Abstract][Full Text] [Related]
16. Beta-endorphin: peripheral opioid activity of homologues from six species.
Ho CL; Ko JL; Li CH
Int J Pept Protein Res; 1987 Apr; 29(4):521-4. PubMed ID: 2954920
[TBL] [Abstract][Full Text] [Related]
17. In vitro evaluation of a casomorphin related pentapeptide, a competitive mu opioid receptor antagonist.
Davis P; Tourwe D; Delaet N; Kramer TH; Burks TF
Proc West Pharmacol Soc; 1991; 34():429-32. PubMed ID: 1664962
[No Abstract] [Full Text] [Related]
18. Structure-activity relationships of dermorphin analogues containing N-substituted amino acids in the 2-position of the peptide sequence.
Schmidt R; Kálmán A; Chung NN; Lemieux C; Horváth C; Schiller PW
Int J Pept Protein Res; 1995 Jul; 46(1):47-55. PubMed ID: 7558596
[TBL] [Abstract][Full Text] [Related]
19. In vitro and in vivo characterization of opioid activities of endomorphins analogs with novel constrained C-terminus: evidence for the important role of proper spatial disposition of the third aromatic ring.
Yu Y; Shao X; Wang CL; Liu HM; Cui Y; Fan YZ; Liu J; Wang R
Peptides; 2007 Apr; 28(4):859-70. PubMed ID: 17276550
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and activity profiles of novel cyclic opioid peptide monomers and dimers.
Schiller PW; Nguyen TM; Lemieux C; Maziak LA
J Med Chem; 1985 Dec; 28(12):1766-71. PubMed ID: 2999401
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
